Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| UNITY Biotechnology Inc | UBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.48 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.48 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.46 - 3.82 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.48 | USD |
UNITY Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.64M | 14.62M | - | 0 | -39.86M | -2.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
UNITY Biotechnology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UBX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.51 | 1.52 | 1.46 | 1.48 | 50,555 | -0.03 | -1.99% |
| 1 Month | 1.65 | 1.67 | 1.46 | 1.53 | 57,976 | -0.17 | -10.30% |
| 3 Months | 1.71 | 2.02 | 1.46 | 1.67 | 93,202 | -0.23 | -13.45% |
| 6 Months | 1.66 | 2.26 | 1.46 | 1.77 | 94,690 | -0.18 | -10.84% |
| 1 Year | 2.10 | 3.82 | 1.46 | 2.36 | 112,761 | -0.62 | -29.52% |
| 3 Years | 50.30 | 53.00 | 1.46 | 12.76 | 742,589 | -48.82 | -97.06% |
| 5 Years | 79.70 | 154.40 | 1.46 | 28.85 | 669,883 | -78.22 | -98.14% |
UNITY Biotechnology Description
| Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. |
